Literature DB >> 30092746

Insights on inhibition of Plasmodium falciparum plasmepsin I by novel epoxyazadiradione derivatives - molecular docking and comparative molecular field analysis.

Mahalakshmi Thillainayagam1, Kullappan Malathi1, Anand Anbarasu1, Harpreet Singh2, Renu Bahadur2, Sudha Ramaiah1.   

Abstract

In the present study, we have explored the anti-malarial potential of epoxyazadiradione, the natural entity extracted from the neem seed oil and its chemical derivatives, against Plasmodium falciparum. The Surflex dock analysis of 41 compounds against an indispensable target, plasmepsin I (PM-I) revealed that around 70% of the compounds are found to have good binding capacity with the consensus score (C-score) of 5 to 4 with few hydrogen bonds. To elucidate the major structural requirements, vital for binding with the plasmepsin enzyme and to develop the predictive models, three-dimentional quantitative structural activity relationship (3D-QSAR) - comparative molecular field analysis (CoMFA) was carried out using Sybyl X.0. Robust and predictive models were obtained with cross-validated correlation coefficient (q2) value of 0.967 and the non-cross-validated correlation coefficient (r2) value of 0.825, which were validated by an external test set with the predictive correlation coefficient r2(pred) values of 0.773. Three zones were identified for substitution with bulky groups and one zone for substitution with non-bulky groups. Three positions favouring the electronegative group substitution and one for the electropositive group substitution were identified. The physicochemical properties of ligands with the highest C-score were studied. Communicated by Ramaswamy H. Sarma.

Entities:  

Keywords:  CoMFA; epoxyazadiradione; molecular docking

Mesh:

Substances:

Year:  2018        PMID: 30092746     DOI: 10.1080/07391102.2018.1510342

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102


  2 in total

1.  Study on mechanism of matrine in treatment of COVID-19 combined with liver injury by network pharmacology and molecular docking technology.

Authors:  Fangzhou Liu; Yuanbai Li; Yang Yang; Meng Li; Yu Du; Yiying Zhang; Jing Wang; Yujing Shi
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

2.  Structure-based screening of natural product libraries in search of potential antiviral drug-leads as first-line treatment to COVID-19 infection.

Authors:  S J Aditya Rao; Nandini P Shetty
Journal:  Microb Pathog       Date:  2022-03-22       Impact factor: 3.848

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.